TrialScope Adds Another Clinical Trial Sponsor to Growing Customer Base
JERSEY CITY, N.J., May 28, 2015 – TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced that it is adding another clinical trial sponsor to its growing client list for the PharmaCM clinical trial disclosure platform. The latest sponsor to join TrialScope’s client list selected the PharmaCM platform to replace an existing commercial product that had been previously implemented.
The new account represents continued growth for TrialScope since the company acquired the PharmaCM platform in June 2014. Currently, over 8,000 users around the world are managing almost 30,000 clinical trial registrations using the PharmaCM platform.
Mike Forgash, CEO, TrialScope, commented, “The TrialScope team looks forward to working with a new sponsor team and adding to its growing roster of satisfied clients. Our expanding customer base is a testament to the simplicity, efficiency and overall value that our zero-footprint solutions bring to complex clinical trial disclosure processes. Our team’s strong reputation for depth of knowledge and breadth of experience is attractive to clients of all sizes who are looking to stay ahead of the curve regarding ever-changing global regulatory requirements and need a disclosure-driven solution as opposed to simply a technology. This is especially important as emerging regulations (such as the EU Clinical Trials Regulation) add complexity to global trial disclosure processes.”
Thomas Wicks, Chief Strategy Officer, noted that the TrialScope team is leveraging its “Rapid Path to Compliance,” a proven engagement methodology based on collaboration and compliance and focused on quickly implementing the PharmaCM platform and decreasing the client’s time to productivity. He added, “As new clients come aboard, we have a unique chance to partner with them to transform their business practices and lower risks of non-compliance. Our practical knowledge is baked into our Rapid Path to Compliance methodology so clients get the combined benefits of our experience and our technology platform to simplify compliance and increase productivity.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
